Detail Katalog

ID: 3250
Cover Merck Druggernaunt :  the Inside Story of a Pharmaceutical Giant / Fran Howthorne

Merck Druggernaunt : the Inside Story of a Pharmaceutical Giant / Fran Howthorne

Pengarang:
Howthorne, Fran
Penerbit:
John Wiley & Sons,
Tempat Terbit:
New Jersey :
Tahun Terbit:
2003
Bahasa:
eng
Subjek
Merck & Co -- Pharmaceutical Industry-United States
Deskripsi Fisik:
xiv, 290 p. ; 22 cm.
ISBN:
0-471-22878-8
Nomor Panggil:
338.70973 HOW m
Control Number:
INLIS000000000003250
BIB ID:
0010-0520003250
Catatan
Indeks : p. 282-290 ; p. 279-282 ; An in--depth look at big pharma's flagship company This book takes readers inside Merck, the world's second most profitable drug company and maker of the world's bestselling drug, Prilosec. Consistently named one of Fortune magazine's Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author the one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much--needed insight on the cutthroat world of pharmaceuticals. It's a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business's most recognizable names.
Status
Tersedia di OPAC Bibliografi Nasional Indonesia Karya Tulis Ilmiah Nasional
Informasi Eksemplar & Metadata
Nomor Barcode Nomor Panggil Akses Lokasi Ketersediaan
00000011227 338.70973 HOW m Dapat dipinjam Mahkamah Konstitusi RI Tersedia
00000011228 338.70973 HOW m Dapat dipinjam Mahkamah Konstitusi RI Tersedia
Format MARC21 - Total 23 field
Tag Ind1 Ind2 Nilai Urutan
001 _ _ INLIS000000000003250 1
005 _ _ 20221026100548 2
035 # # $a 0010-0520003250 3
008 _ _ 221026################|##########|#eng## 4
020 # # $a 0-471-22878-8 5
041 _ _ $a eng 6
082 # # $a 338.70973 7
084 # # $a 338.70973 HOW m 8
100 _ # $a Howthorne, Fran 9
245 1 4 $a Merck Druggernaunt : $b the Inside Story of a Pharmaceutical Giant /$c Fran Howthorne 10
260 # # $a New Jersey :$b John Wiley & Sons,$c 2003 11
300 # # $a xiv, 290 p. ; $c 22 cm. 12
500 # # $a Indeks : p. 282-290 13
504 # # $a p. 279-282 14
520 # # $a An in--depth look at big pharma's flagship company This book takes readers inside Merck, the world's second most profitable drug company and maker of the world's bestselling drug, Prilosec. Consistently named one of Fortune magazine's Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author the one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much--needed insight on the cutthroat world of pharmaceuticals. It's a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business's most recognizable names. 15
650 _ 4 $a Merck & Co 16
650 _ 4 $a Pharmaceutical Industry-United States 17
990 # # $a 11227/MKRI-P/XII-2008 18
990 # # $a 11228/MKRI-P/XII-2008 19
990 # # $a 11227/MKRI-P/XII-2008 20
990 # # $a 11228/MKRI-P/XII-2008 21
990 # # $a 11228/MKRI-P/XII-2008 22
990 # # $a 11227/MKRI-P/XII-2008 23
Penjelasan Field MARC21:
  • 001: Control Number
  • 005: Date and Time of Latest Transaction
  • 020: ISBN
  • 100: Main Entry - Personal Name
  • 245: Title Statement
  • 250: Edition Statement
  • 260: Publication Information
  • 300: Physical Description
  • 650: Subject
  • 700: Added Entry - Personal Name
Informasi Katalog

Ditambahkan: 30 Dec 2008
Disetujui OPAC: 08 May 2020
Export